Imaging end points for monitoring neuroprotection in Parkinson's disease
- PMID: 12666103
- DOI: 10.1002/ana.10480
Imaging end points for monitoring neuroprotection in Parkinson's disease
Abstract
In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is considered. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective approaches to PD.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical